CreditReports.dk
HomeScreen companies

PHARMA NORD EXPORT ApS Financials, key figures and credit report

CVR number: 70996510 Established 1982 Industry: 46 Wholesale trade
Company contact details
Sadelmagervej 30-32, 7100 Vejle webmaster@pharmanord.dk tel: 75857474
Gross profit 37 743.0 kDKK FY 2025 +7.7% vs 2024
EBIT 18 748.0 kDKK FY 2025 +65.7% vs 2024
Net debt 14 484.0 kDKK FY 2025 +59.8% vs 2024
Quick ratio 0.8 FY 2025 -0.1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit26 012.0326 459.5232 656.0335 053.0037 743.00
Employee benefit expenses-21 350.85-20 685.08-22 155.65-23 048.00-21 919.00
Other operating expenses-33.85-9.82-24.89-62.00- 131.00
Total depreciation-1 211.37-1 198.67-1 253.05-1 127.00-1 081.00
Reduction in value of non-current assets375.004 000.00
EBIT3 415.964 565.969 222.4411 315.0018 748.00
Other financial income1 715.74336.02655.19532.00398.00
Other financial expenses- 917.70-1 829.06-1 030.41-1 094.00-3 079.00
Pre-tax profit4 214.003 072.928 847.2210 702.0016 000.00
Income taxes-1 025.62- 943.25-2 496.33-3 241.00-4 484.00
Net earnings3 188.382 129.676 350.897 461.0011 516.00

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Land and waters35 715.4435 282.7634 850.076 480.0014 360.00
Buildings37 000.0041 000.00
Machinery and equipment2 648.912 689.072 627.033 243.003 199.00
Tangible assets total38 364.3537 971.8337 477.1146 723.0058 559.00
Investments total
Long term receivables total
Raw materials and consumables17 840.0023 501.00
Finished products/goods18 689.3717 757.5812 826.28
Inventories total18 689.3717 757.5812 826.2817 840.0023 501.00
Current trade debtors17 624.1711 659.3113 813.2515 689.0019 816.00
Current amounts owed by group member comp.18 555.769 443.7512 579.00
Prepayments and accrued income127.25186.96492.83443.00364.00
Current other receivables2 312.44912.51962.309 366.0024 141.00
Short term receivables total20 063.8631 314.5424 712.1338 077.0044 321.00
Other current investments26 452.37
Cash and bank deposits12 756.0515 408.8411 358.246 444.005 676.00
Cash and cash equivalents39 208.4115 408.8411 358.246 444.005 676.00
Balance sheet total (assets)116 325.99102 452.7986 373.77109 084.00132 057.00

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital200.00200.00200.00200.00200.00
Asset revaluation reserve7 575.667 497.447 419.236 240.00
Shares repurchased15 000.0015 000.008 000.00
Retained earnings32 979.1021 221.2223 413.6421 609.0020 972.00
Profit of the financial year3 188.382 129.676 350.897 461.0011 516.00
Minority interest (BS)58.0168.64103.09125.00117.00
Shareholders equity total44 001.1546 116.9837 486.8544 395.0047 045.00
Provisions7 030.666 967.877 087.127 154.0010 098.00
Non-current loans from credit institutions11 253.4210 574.2210 023.809 468.0013 635.00
Non-current liabilities total11 253.4210 574.2210 023.809 468.0013 635.00
Current loans from credit institutions1 044.391 122.92607.35556.005 708.00
Current trade creditors1 376.191 789.702 617.243 447.001 981.00
Current owed to participating5 250.005 481.00197.00
Current owed to group member7 707.88620.00
Short-term deferred tax liabilities526.67122.461 257.011 479.001 917.00
Other non-interest bearing current liabilities43 385.6235 758.6422 044.4137 104.0050 856.00
Current liabilities total54 040.7638 793.7231 776.0148 067.0061 279.00
Balance sheet total (liabilities)116 325.99102 452.7986 373.77109 084.00132 057.00
Page generated